A phase 1, open-label, drug–drug interaction study of rucaparib with rosuvastatin and oral contraceptives in patients with advanced solid tumors
Liao, Mingxiang, Jeziorski, Krzysztof G., Tomaszewska-Kiecana, Monika, Láng, István, Jasiówka, Marek, Skarbová, Viera, Centkowski, Piotr, Ramlau, Rodryg, Górnaś, Maria, Lee, John, Edwards, Sarah, Habeck, Jenn, Nash, Eileen, Grechko, Nikolay, Xiao, Jim J.
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Published in Cancer chemotherapy and pharmacology (01.11.2021)
Get full text
Journal Article
The pharmacokinetics of pamiparib in the presence of a strong CYP3A inhibitor (itraconazole) and strong CYP3A inducer (rifampin) in patients with solid tumors: an open-label, parallel-group phase 1 study
Mu, Song, Lin, Chester, Skrzypczyk-Ostaszewicz, Anna, Bulat, Iurie, Maglakelidze, Marina, Skarbova, Viera, Andreu-Vieyra, Claudia, Sahasranaman, Srikumar
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Published in Cancer chemotherapy and pharmacology (01.07.2021)
Get full text
Journal Article
Pharmacokinetics and safety of rucaparib in patients with advanced solid tumors and hepatic impairment
Grechko, Nikolay, Skarbova, Viera, Tomaszewska-Kiecana, Monika, Ramlau, Rodryg, Centkowski, Piotr, Drew, Yvette, Dziadziuszko, Rafal, Zemanova, Milada, Beltman, Jeri, Nash, Eileen, Habeck, Jenn, Liao, Mingxiang, Xiao, Jim
Published in Cancer chemotherapy and pharmacology (01.08.2021)
Published in Cancer chemotherapy and pharmacology (01.08.2021)
Get full text
Journal Article